Alumis Inc. specializes in developing precision therapies for immune-mediated diseases. Committed to transforming patient lives, the company leverages innovative approaches to design targeted treatments, addressing unmet medical needs in the biotechnology and life sciences industry.
Competitors of Alumis are Amgen, Biogen, Regeneron Pharmaceuticals, Gilead Sciences, Vertex Pharmaceuticals, Celgene (now part of Bristol-Myers Squibb), Novartis, Sanofi, Eli Lilly and Company, AbbVie.
What does Alumis do?
Alumis Inc. specializes in developing precision therapies for immune-mediated diseases. Committed to transforming patient lives, the company leverages innovative approaches to design targeted treatments, addressing unmet medical needs in the biotechnology and life sciences industry.